Silence Therapeutics
SLN
#5861
Rank
S$1.57 B
Marketcap
S$25.29
Share price
0.05%
Change (1 day)
193.93%
Change (1 year)

EPS for Silence Therapeutics (SLN)

EPS in 2026 (TTM): S-$2.08

According to Silence Therapeutics's latest financial reports the company's current EPS (TTM) is S-$2.07. In 2025 the company made an earnings per share (EPS) of S-$2.42 a decrease over its 2024 EPS that were of S-$1.27.

EPS history for Silence Therapeutics from 1996 to 2026

Annual EPS

Year EPS Change
2026 (TTM)S-$2.08-14.1%
2025S-$2.4290.91%
2024S-$1.27-32.65%
2023S-$1.88-5.77%
2022S-$2.00-13.03%
2021S-$2.3010.23%
2020S-$2.0858.5%
2019S-$1.312.94%
2018S-$1.28969.59%
2017S-$0.12-79.18%
2016S-$0.57-3.11%
2015S-$0.59-55%
2014S-$1.313.83%
2013S-$1.27-84.88%
2012S-$8.38134.19%
2011S-$3.58-61.8%
2010S-$9.36-45.65%
2009S-$17.23-1.16%
2008S-$17.434.29%
2007S-$16.7210.54%
2006S-$15.12-22.29%
2005S-$19.46-57.32%
2004S-$45.5939.1%
2003S-$32.7870.67%
2002S-$19.20-25.17%
2001S-$25.675.29%
2000S-$24.38-24.54%
1999S-$32.3026.7%
1998S-$25.50-11.73%
1997S-$28.8872.24%
1996S-$16.77